Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR7 is a G protein-coupled chemokine receptor crucial for directing immune cell trafficking to secondary lymphoid organs. It plays a significant role in immune surveillance, adaptive immunity, and various pathological conditions like cancer metastasis and chronic inflammatory diseases. CCR7 binds to chemokines CCL19 and CCL21, guiding the migration of T lymphocytes and dendritic cells to lymph nodes. As such, it represents a potential therapeutic target for immunomodulation in cancer, autoimmune disorders, hypertension, and inflammation.
CCR7 antagonists inhibit receptor activation and subsequent immune cell migration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C Motif Chemokine Receptor 7 (CCR7).